Abstract
An open, multi-centre study was carried out to assess the ease with which a patient could be instructed to use the terbutaline 'Turbohaler' ('Bricanyl Turbohaler') and whether benefit was obtained and technique still satisfactory 4 weeks later. Asthmatic patients not receiving oral steroids were eligible; 138 completed the study. There were consistent increases in PEFR and FEV1 at the start and end of the study on using the 'Bricanyl Turbohaler'. Over 80% of patients used it correctly in every respect fulfilling each of 8 criteria and 96% found it easy to use. It was easy to instruct patients to use the 'Turbohaler', patients continued to use it correctly after a month and obtained sustained benefit.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
